Genertec Universal Medical Group Company Limited (UNI MEDICAL) announced that its wholly owned subsidiary, Genertec Universal International Financial Leasing (Tianjin) Co., Ltd., has successfully completed the first tranche of its 2026 domestic medium-term notes (T1 Notes).
The offering, finalized on 27 May 2026, raised RMB300.00 million through notes priced at par (RMB100.0 per note). The T1 Notes carry a fixed coupon of 1.82% and mature two years from the issue date, setting the maturity in May 2028.
The transaction follows the board’s prior disclosure on 25 May 2026 and forms part of the company’s previously announced RMB0.30 billion medium-term note programme for 2026. All proceeds were secured within the targeted size, and issuance terms were consistent with the board’s guidance.
Executive responsibility for the disclosure rests with Chairman Chen Shisu, according to the filing with The Stock Exchange of Hong Kong Limited on 27 May 2026.
Comments